Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,855Revenue $M297Net Margin (%)-88.8Z-Score1.9
Enterprise Value $M4,021EPS $-3.2Operating Margin %-2.9F-Score4
P/E(ttm))0Cash Flow Per Share $-1.7Pre-tax Margin (%)-90.8Higher ROA y-yN
Price/Book7.010-y EBITDA Growth Rate %0Quick Ratio1.2Cash flow > EarningsY
Price/Sales8.75-y EBITDA Growth Rate %0Current Ratio1.3Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-42.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-159.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M125ROI % (ttm)-72.1Gross Margin Increase y-yY

Gurus Latest Trades with HZNP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HZNPJoel Greenblatt 2014-12-31 Add$10.61 - $13.47
($12.51)
$ 30.8259%Add 33.48%107,898
HZNPJoel Greenblatt 2014-09-30 Add$8.265 - $16.27
($11.52)
$ 30.8263%Add 39.93%80,834
HZNPJoel Greenblatt 2014-06-30 Buy 0.01%$12.02 - $16.32
($14.25)
$ 30.8254%New holding57,769
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HZNP is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


HZNP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Himawan JeffDirector 2015-03-13Sell554,564$22.4437.34view
Himawan JeffDirector 2015-03-10Sell1,614,827$21.8541.05view
Himawan JeffDirector 2014-11-19Sell3,450,000$12.05155.77view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2014-11-19Sell24,999$12.05155.77view
Walbert Timothy PChairman, President and CEO 2014-11-19Sell150,000$12.05155.77view
Nohria VirinderDirector 2014-11-13Sell2,000,000$11.54167.07view
VENKATARAMAN BALAJIFormer 10% Owner 2014-11-13Sell6,086,957$11.54167.07view
Nohria VirinderDirector 2014-11-13Sell1,739,130$11.54167.07view
Kelly David GeorgeEVP & Corporate Secretary 2014-11-06Sell0$0167.07view
DE VAERE ROBERT JEVP & CFO 2014-09-30Sell51,942$12.28150.98view

Press Releases about HZNP :

    Quarterly/Annual Reports about HZNP:

    News about HZNP:

    Articles On GuruFocus.com
    M&A’s Driving The Stock Indexes Ahead Apr 06 2015 
    Biotech Effectiveness: Horizon Pharma, Zafgen, XOMA Corp Mar 09 2015 
    Horizon Pharma plc to Host Fourth Quarter 2014 Conference Call and Webcast on February 27, 2015 Jan 28 2015 
    Horizon Pharma plc Provides Business Update Jan 12 2015 
    Horizon Pharma plc Files Patent Infringement Lawsuit Against Watson Laboratories, Inc. for Filing an Dec 24 2014 
    Horizon Pharma plc to Present at the 26th Annual Piper Jaffray Healthcare Conference Nov 24 2014 
    Horizon Pharma plc Announces Pricing of Secondary Offering of Ordinary Shares by Selling Shareholder Nov 14 2014 
    Horizon Pharma plc Announces Proposed Secondary Offering of Ordinary Shares by Selling Shareholders Nov 13 2014 
    Horizon Pharma plc Announces Favorable Markman Ruling in RAYOS(R) (prednisone) Delayed-Release Table Nov 12 2014 
    Horizon Pharma plc Appoints John J. Kody as Executive Vice President and Chief Commercial Officer Nov 06 2014 


    More From Other Websites
    5 ETF Trends To Watch As Assets, Strategies Multiply Apr 17 2015
    IPO Summit Materials A Bright Spot In Ugly Session Apr 17 2015
    8 IBD 50 Stocks Bucking The Market Sell-Off Apr 17 2015
    Stocks Stumble At Starting Bell; American Express Takes A Dive Apr 17 2015
    Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice... Apr 17 2015
    7:01 am Horizon Pharma announces it received a Notice of Allowance from the USPTO for the U.S.... Apr 17 2015
    Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice... Apr 17 2015
    The Medicines Co.'s Kengreal Backed for FDA Approval - Analyst Blog Apr 16 2015
    HORIZON PHARMA PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 16 2015
    Horizon Pharma (HZNP) Stock Rises in After-Hours Trading Following Pricing of Secondary Offering Apr 16 2015
    Horizon Pharma PLC (HZNP), Apple Inc. (AAPL): How Billionaire Mark Kingdon’s Picks Performed in Q1 Apr 16 2015
    Carbylan Therapeutics Inc (CBYL): Broadfin’s Latest Move and Market Smashing Q1 Returns Inside Apr 16 2015
    Amgen Gets FDA Nod for Chronic Heart Failure Drug Corlanor - Analyst Blog Apr 16 2015
    Horizon Pharma plc Announces Pricing of Public Offering of Ordinary Shares Apr 15 2015
    IBD Market Wrap - 04/15/15 Apr 15 2015
    Horizon Pharma plc Announces Pricing of Public Offering of Ordinary Shares Apr 15 2015
    Stocks Off Best Levels; Smith & Wesson Ups Guidance Apr 15 2015
    Stocks Climb In Solid Trade; Delta Air, Intel Early Leaders Apr 15 2015
    Jim Cramer's 'Mad Money' Recap: 6 Positive Things You Should Keep in Focus Apr 14 2015
    Cramer Remix: This company's worth double Apr 14 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK